(BTAI) Bioxcel Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Bioxcel Therapeutics | (BTAI) share price targets
Complete technical analysis of Bioxcel Therapeutics (BTAI) by charts plus indicators, forecast predictions and share price targets for Bioxcel Therapeutics (BTAI)
Bioxcel Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-15 View latest technical analysis
10 day averaged volume of Bioxcel Therapeutics is 506890
Date | Daily Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 0.57 | 0.55 | 0.57 | 0.52 | 0.884 times |
14 Thu Nov 2024 | 0.52 | 0.63 | 0.63 | 0.50 | 1.473 times |
13 Wed Nov 2024 | 0.62 | 0.69 | 0.69 | 0.59 | 1.066 times |
12 Tue Nov 2024 | 0.67 | 0.68 | 0.72 | 0.65 | 1.505 times |
11 Mon Nov 2024 | 0.72 | 0.68 | 0.72 | 0.66 | 1.344 times |
08 Fri Nov 2024 | 0.68 | 0.69 | 0.69 | 0.65 | 0.598 times |
07 Thu Nov 2024 | 0.67 | 0.72 | 0.76 | 0.65 | 1.51 times |
06 Wed Nov 2024 | 0.73 | 0.66 | 0.74 | 0.66 | 1.02 times |
05 Tue Nov 2024 | 0.68 | 0.63 | 0.68 | 0.63 | 0.454 times |
04 Mon Nov 2024 | 0.64 | 0.66 | 0.66 | 0.62 | 0.482 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 0.6, but if it comes above 0.6, then a intra day buy could be more profitable.
If you take a sell trade below 0.6, then use 0.6 as stoploss and 0.5 as target. However if you take a buy trade in stock , then use 0.6 as stoploss and 0.64 as target.
Share price targets for Bioxcel Therapeutics (BTAI)
Target Type | Value |
Downside Target | 0.50 |
Downside Target | 0.51 |
Downside Target | 0.54 |
Upside Target | 0.58 |
Upside Target | 0.61 |
Upside Target | 0.65 |
Upside Target | 0.72 |
Upside Target | 0.76 |
Upside Target | 0.83 |
Upside Target | 0.84 |
Upside Target | 1.04 |
Upside Target | 1.13 |
Upside Target | 1.37 |
Intraday share price targets for Bioxcel Therapeutics (BTAI)
Target Type | Value |
Downside Intraday Target | 0.47 |
Downside Intraday Target | 0.38 |
Upside Intraday Target | 0.69 |
Upside Intraday Target | 0.82 |
Upside Intraday Target | 0.6 |
Weekly technical analysis of Bioxcel Therapeutics (BTAI)
Date | Weekly Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 0.57 | 0.68 | 0.72 | 0.50 | 1.543 times |
08 Fri Nov 2024 | 0.68 | 0.66 | 0.76 | 0.62 | 0.788 times |
01 Fri Nov 2024 | 0.64 | 0.61 | 0.83 | 0.61 | 1.984 times |
25 Fri Oct 2024 | 0.61 | 0.58 | 0.65 | 0.54 | 0.937 times |
18 Fri Oct 2024 | 0.57 | 0.53 | 0.59 | 0.52 | 0.839 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Bioxcel Therapeutics (BTAI)
Date | Monthly Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 0.57 | 0.67 | 0.76 | 0.50 | 0.651 times |
31 Thu Oct 2024 | 0.67 | 0.61 | 0.83 | 0.51 | 0.618 times |
30 Mon Sep 2024 | 0.61 | 0.63 | 0.84 | 0.51 | 1.252 times |
30 Fri Aug 2024 | 0.62 | 1.11 | 1.13 | 0.58 | 0.852 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Bioxcel Therapeutics (BTAI)
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Bioxcel Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Bioxcel Therapeutics in short term but the sell signal is initial and weak.
Bioxcel Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Bioxcel Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Bioxcel Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.65 and Bioxcel Therapeutics (BTAI) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Bioxcel Therapeutics (BTAI) stock. Volume based technical analysis of Bioxcel Therapeutics (BTAI) stock is negative.
Bioxcel Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Bioxcel Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Bioxcel Therapeutics in short term but the sell signal is initial and weak.
Bioxcel Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Bioxcel Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Bioxcel Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.65 and Bioxcel Therapeutics (BTAI) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Bioxcel Therapeutics (BTAI) stock. Volume based technical analysis of Bioxcel Therapeutics (BTAI) stock is negative.
Bioxcel Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.